-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – mRNA-1045 in Respiratory Syncytial Virus (RSV) Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.MRNA-1045 in Respiratory Syncytial Virus (RSV) Infections Drug Details:mRNA-1045 is under development for the prevention of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Sytalizumab in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sytalizumab in Solid Tumor Drug Details: Sytalizumab is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AGI-134 in Sarcomas
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AGI-134 in Sarcomas Drug Details: AGI-134 is under development for the treatment of solid tumors,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Aflibercept Biosimilar in Wet (Neovascular / Exudative) Macular Degeneration
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aflibercept Biosimilar in Wet (Neovascular / Exudative) Macular Degeneration Drug Details: Aflibercept biosimilar (AVT06)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PM-534 in Hormone Sensitive Breast Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.PM-534 in Hormone Sensitive Breast CancerDrug Details: PM-534 is under development for the treatment of advanced...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IO-112 in Polycythemia Vera
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. IO-112 in Polycythemia Vera Drug Details: IO-112 is under development for the treatment of essential...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Epinephrine in Anaphylaxis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Epinephrine in Anaphylaxis Drug Details: Epinephrine (ARS-1) is under development for the treatment of anaphylaxis...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Malignant Mesothelioma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.PRO-1184 in Malignant Mesothelioma Drug Details:PRO-1184 is under development for the treatment of solid tumors such...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.PRO-1184 in Solid Tumor Drug Details:PRO-1184 is under development for the treatment of solid tumors such...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ASKG-712 in Wet (Neovascular / Exudative) Macular Degeneration
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.ASKG-712 in Wet (Neovascular / Exudative) Macular Degeneration Drug Details:ASKG-712 is under development for the treatment...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.